par traitement local Étude de phase IIb 1 Dermatite atopique EADV 2014 Daprès Thaçi D et al abstract FC0804 actualisé Aspects cliniques Barrière cutanée endommagée Dysrégulation immunitaire ID: 524499
Download Presentation The PPT/PDF document "Sécurité et efficacité du dupilumab c..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
